(Q30932195)

27 June 2017

1 reference

title

Coronary vasoconstrictor potential of triptans: a review of in vitro pharmacologic data (English)

1 reference

27 June 2017

author name string

Antoinette Maassen Van Den Brink

series ordinal

1

1 reference

27 June 2017

Pramod R Saxena

series ordinal

2

1 reference

27 June 2017

publication date

1 May 2004

1 reference

27 June 2017

1 reference

27 June 2017

volume

44 Suppl 1

1 reference

27 June 2017

page(s)

S13-9

1 reference

5-Hydroxytryptamine contracts human coronary arteries predominantly via 5-HT2 receptor activation

27 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2004.04104.X

Comparison of contractile responses to 5-hydroxytryptamine and sumatriptan in human isolated coronary artery: synergy with the thromboxane A2-receptor agonist, U46619

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2004.04104.X

Coronary side-effect potential of current and prospective antimigraine drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2004.04104.X

Variable participation of 5-HT1-like receptors and 5-HT2 receptors in serotonin-induced contraction of human isolated coronary arteries. 5-HT1-like receptors resemble cloned 5-HT1D beta receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2004.04104.X

Augmented contraction of the human isolated coronary artery by sumatriptan: a possible role for endogenous thromboxane

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2004.04104.X

Characterization of sumatriptan-induced contractions in human isolated blood vessels using selective 5-HT(1B) and 5-HT(1D) receptor antagonists and in situ hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2004.04104.X

Development and characterisation of human 5-HT1B- or 5-HT1D-receptor specific antibodies as unique research tools

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2004.04104.X

Effects of the novel high-affinity 5-HT(1B/1D)-receptor ligand frovatriptan in human isolated basilar and coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2004.04104.X

5-HT1D receptor agonists and human coronary artery reactivity in vitro: crossover comparisons of 5-HT and sumatriptan with rizatriptan and L-741,519

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2004.04104.X

Comparison of the vasoconstrictor effects of rizatriptan and sumatriptan in human isolated cranial arteries: immunohistological demonstration of the involvement of 5-HT1B-receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2004.04104.X

A comparison of the contractile effects of 5-hydroxytryptamine, sumatriptan and MK-462 on human coronary artery in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2004.04104.X

Vascular effects of the new anti-migraine agent almotriptan on human cranial and peripheral arteries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2004.04104.X

Contribution of dynamic vascular wall thickening to luminal narrowing during coronary arterial constriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2004.04104.X

Endothelial dysfunction in the absence of coronary atheroma causing Prinzmetal's angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2004.04104.X

10.1111/J.1526-4610.2004.04104.X

21 January 2018

Identifiers

DOI

1 reference

27 June 2017

1 reference